Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Two new projects led by Tal Arnon and Irina Udalova have been awarded Medical Research Council (MRC) funding.

Tal Arnon and Irina Udalova

Tal Arnon will study the role of resident memory B (BRM) cells in protecting the lungs infected with the influenza virus.

The MRC grant will enable the Arnon Lab to further understand how pre-existing antibodies provide immunity against influenza, which is a major threat to human health that causes over 500,000 deaths per year globally. Tal's lab has already led a pioneering study exploring the dynamic behaviour of a unique subset of memory B cells that develop within the lungs following infection with the influenza virus. The research can now continue to discover how these cells differentiate into antibody producing cells and their role in establising short- and long-term immunity against influenza virus.

Speaking about the funding Tal said: "We are very excited to receive this funding and to further explore the role of resident memory B cells in protecting against the flu virus. Understanding the molecular mechanisms that regulate this process will help to guide the development of new and more effective vaccine strategies to prevent the spread of influenza variants."

Irina Udalova's MRC grant will enable the study of the mechanisms contributing to inflammatory bowel diseases (IBD) such as such as Crohn's disease (CD) and Ulcerative Colitis, which are estimated to affect 1 in every 100 people in the UK. Irina's recent work decoded molecular wiring of innate immune cells, called neutrophils, and identified key control hubs amendable to tailored therapeutic targeting. "However, the specific role of neutrophils during colitis remains largely unexplored," said Irina. The team will now be asking what role neutrophils play in the initiation of intestinal inflammation that leads to IBD.

Using cutting-edge imaging technology, single cell genomic approaches and unique tools modulating neutrophil activity in vitro and in vivo models, the team will examine the functional impact of controlled modulation of neutrophil activity on the intestinal inflammation. Irina hopes the project will lead to the development of a new class of therapeutic strategies, based on selective modulation of neutrophil biology. "This MRC award will allow us to build our knowledge of their role in disease and offers hope for future treatments of the condition," said Irina.

Similar stories

NIHR Fellowships awarded to NDORMS researchers

Congratulations to Eileen Morrow and Mae Chester-Jones who have received NIHR Doctoral Fellowships

ORUK Early Career Research Fellowship awarded to NDORMS researcher

Congratulations to Jack Tu who has been awarded an Orthopaedic Research UK Early Career Research Fellowship to explore the cause of knee pain after total knee replacement.

OCTRU - delivering answers to important clinical questions

The Oxford Clinical Trials Research Unit (OCTRU) has received NIHR benchmarking results and offers excellent value for money according to the report

Unhelpful thoughts about fracture symptoms hinder recovery

The importance of mindsets and feelings about fracture symptoms have been shown to be a key factor in recovery of musculoskeletal conditions.

Fat tissues can play a protective role against inflammation in the intestine

A new study in The EMBO Journal has revealed how fat tissues might provide a protective role in intestinal inflammation opening new lines of research into the treatment of inflammatory bowel diseases.

NDORMS researchers awarded Sir Henry Wellcome Fellowships

Kennedy Institute researchers Mariana Borsa and Edward Jenkins have both been awarded Sir Henry Wellcome Postdoctoral Fellowships, which give recently qualified postdoctoral researchers the opportunity to start independent research careers.